GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Q2 FY27 Revenue up 32% to Rs 2,710 Million

RESULTS ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 02 Nov 2026, 06:38 PM IST  ·  BSE ID: 24b7771a-e92f-4c91-9d41-f362169b0dc2
View Original BSE Filing (PDF)
💡
In Simple Terms
Krsnaa Diagnostics achieved its highest quarterly revenue ever, increasing to Rs 2,710 million in Q2 FY27.
🤖 AI Summary
  • Krsnaa Diagnostics recorded its highest ever quarterly revenue of Rs 2,710 million in Q2 FY27, up 32% YoY.
  • Half-year FY27 Revenue increased 27% to Rs 5,065 million, driven by new projects and existing operations.
  • Profit After Tax (PAT) for Q2 FY27 was Rs 246 million, compared to Rs 239 million in Q2 FY26.
  • Retail business revenue grew 35% YoY to Rs 235 million, contributing about 9% to total revenue.
  • PAT for H1 FY27 was Rs 411 million, a decrease from Rs 445 million in H1 FY26 due to upfront expenditure.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q2 FY27)
2,710 million
Revenue from Operations (Q2 FY26)
2,060 million
Revenue from Operations (H1 FY27)
5,065 million
Revenue from Operations (H1 FY26)
3,990 million
EBITDA (Q2 FY27)
719 million
EBITDA (Q2 FY26)
602 million
EBITDA (H1 FY27)
1,307 million
EBITDA (H1 FY26)
1,126 million
EBITDA Margin % (Q2 FY27)
27%
EBITDA Margin % (Q2 FY26)
29%
EBITDA Margin % (H1 FY27)
26%
EBITDA Margin % (H1 FY26)
28%
Profit After Tax (PAT) (Q2 FY27)
246 million
Profit After Tax (PAT) (Q2 FY26)
239 million
Profit After Tax (PAT) (H1 FY27)
411 million
Profit After Tax (PAT) (H1 FY26)
445 million
PAT Margin % (Q2 FY27)
9%
PAT Margin % (Q2 FY26)
12%
PAT Margin % (H1 FY27)
8%
PAT Margin % (H1 FY26)
11%
Retail Revenue (Q2 FY27)
235 million
🏢 How This Affects the Company
📈
Business Impact
The company's revenue growth, including contributions from newly operationalized projects and retail expansion, indicates an increasing market presence in diagnostic services.
💰
Financial Impact
Revenue from operations increased, while Profit After Tax for H1 FY27 saw a moderation due to upfront expenditures related to the Rajasthan project.
⚙️
Operational Impact
Continued focus on stabilizing and improving utilization across PPP projects, alongside expansion of radiology operations and NABL/NABH accredited centers, reflects ongoing operational development.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with reported revenue growth and changes in profitability metrics. H1 FY27 PAT moderated to Rs 411 million.
🔍
Management Signal
Management indicates a focus on strengthening existing PPP presence, capitalizing on growth opportunities, and accelerating retail diagnostics as a complementary growth engine.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 results — monitor for impact of Rajasthan project benefits on PAT.
Operational metrics — observe utilization improvements across PPP projects and network.
Retail business growth — track sustained momentum in patient and test volumes.
MEDIUM RISK Moderation in H1 FY27 PAT due to upfront expenditure introduces a short-term profitability concern.
💡 Investor Takeaway
Krsnaa Diagnostics reported Q2 FY27 Revenue from Operations of Rs 2,710 million, a 32% YoY increase from Rs 2,060 million. Half-year FY27 revenue rose 27% to Rs 5,065 million. Q2 FY27 Profit After Tax was Rs 246 million, up from Rs 239 million.
⚖️ Strengths & Concerns

✅ Positives

  • Highest ever quarterly revenue of Rs 2,710 million in Q2 FY27, representing a 32% YoY growth from Rs 2,060 million.
  • Retail business revenue increased 35% YoY to Rs 235 million, with patient volumes up 45% and test volumes up 48%.

⚠️ Concerns

  • Profit After Tax (PAT) for H1 FY27 decreased to Rs 411 million from Rs 445 million in H1 FY26.
  • PAT Margin % declined to 9% in Q2 FY27 from 12% in Q2 FY26, and to 8% in H1 FY27 from 11% in H1 FY26.
📅 Company Track Record
Krsnaa Diagnostics previously reported Q2 FY27 revenue up 32% to INR 2,710 Mn with PAT increasing 3% in an earlier investor presentation on November 02, 2026. Prior to this, the board was scheduled to meet on November 02, 2026, to approve Q2 and half-year FY27 results.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Krsnaa Diagnostics' revenue in Q2 FY27?
Krsnaa Diagnostics reported Revenue from Operations of Rs 2,710 million for Q2 FY27, marking its highest ever quarterly revenue.
How did Krsnaa Diagnostics' half-year revenue for FY27 perform?
Half-year FY27 Revenue for Krsnaa Diagnostics increased 27% to Rs 5,065 million, compared to Rs 3,990 million in H1 FY26.
What was the Profit After Tax (PAT) for Krsnaa Diagnostics in Q2 FY27?
Profit After Tax (PAT) for Krsnaa Diagnostics in Q2 FY27 was Rs 246 million, an increase from Rs 239 million in Q2 FY26.
What was the PAT for Krsnaa Diagnostics in H1 FY27?
The Profit After Tax (PAT) for Krsnaa Diagnostics in H1 FY27 was Rs 411 million, a decrease from Rs 445 million in H1 FY26, primarily due to upfront expenditure towards the Rajasthan project.
What was the growth in Krsnaa Diagnostics' retail business in Q2 FY27?
Krsnaa Diagnostics' retail business revenue grew 35% YoY to Rs 235 million in Q2 FY27, contributing approximately 9% of the overall revenue.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.